Standing ovations for the new daraxonasib at ASCO meeting. Amazing breakthrough, hooray for science!
Ewerslab
Major news from #ASCO26: A multi-selective RAS(ON) inhibitor nearly doubles survival time in people with metastatic pancreatic cancer. “This is absolutely practice-changing” says Dr. Shruti Patel in this Science in Seconds. #pancan
Read the abstract: https://bit.ly/4dChEWM
